Vaccine development is made by preventing pathogenic microorganisms, such as bacteria, rickettsia, viruses, etc. and their metabolites by artificially attenuating, inactivating, transgenic or mutating the genetic code of viral genes. Infectious diseases or become vaccines with therapeutic effects. Vaccines are increasingly important in the prevention of major diseases, and the quality of vaccines is increasing.
RiboBio provides genomic high-throughput sequencing, bioinformatics, oligonucleic acid synthesis and high-content screening services for vaccine development, using bioinformatics methods to predict genes that may become vaccine candidate antigens, and by analyzing the genome sequence of pathogens, predicting pathogens All antigenic information, and then select appropriate candidate antigens, can also develop high-targeted vaccines based on nucleic acid drugs to help the development of a new generation of innovative vaccines.